Desfecho clínico de pacientes obesos diagnosticados com COVID-19 em Unidades de Terapia Intensiva
DOI:
https://doi.org/10.34119/bjhrv6n3-228Keywords:
COVID-19, obesidade, Unidade de Terapia Intensidade, desfecho clínicoAbstract
Introdução: A obesidade é considerada um fator de risco importante para piora das condições clínicas do paciente internato por COVID-19. Objetivo: investigar qual o desfecho clínico dos pacientes obesos diagnosticados com COVID-19 em Unidades de Terapia Intensiva. Metodologia: Revisão Integrativa da Literatura com pesquisa nas bases de dados Pubmed. Resultados: Foram analisados 17 artigos para este estudo. Discussão: O tecido adiposo se torna propenso a invasão viral, vulnerabilizando órgãos como coração e pulmão. Associado a isso, esses pacientes possuem movimento torácico limitado, função respiratória comprometida e pressão abdominal aumentada, o que implica ainda mais na gravidade das infecções pelo COVID-19. Há maior risco para tromboembolismo venoso, de Coagulação Intravascular Dissemina (CIVD) e choque, sendo ainda considerada como fator independente para o agravamento de doenças pré-existentes, como hipertensão arterial e diabetes mellitus. Considerações finais: A obesidade é um fator de risco independente e, modifica o curso da infecção pelo coronavírus. Pacientes com IMC> 30kg/m² e IMC>40kg/m² foram mais associados a pior gravidade e mortalidade, indicando que, quanto maior o IMC, maior a gravidade do quadro clínico e pior o desfecho.
References
WAN D.-Y., LUO X.-Y., DONG W., ZHANG Z.-W. Current practice and potential strategy in diagnosing COVID-19. European Review for Medical and Pharmacological Sciences. 2020; 24:4548-53.
Ejaz Hasan, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–9.
Pranata R., et al. Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis. Diabetes Metab. 2021;47(2):1-10.
Ietz William D, Santos-Burgoa Carlos. Obesity and its Implications for COVID-19 Mortality. The obesity Society. 2020;28(6):1005-1005.
Popkin Barry M. Popkin, et al. Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020:1-17.
Petrakis Demetrios, et al. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality. Mol Med Rep. 2020;22(1):9–19.
Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2020;37(2):1-49.
Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: A systematic review and meta-analysis. Journal of medical virology. 2021;93(1):257–61.
Morais AHA, Passos TS, Vale SHL, Maia JKS, Maciel BLL. Obesity and the increased risk for COVID-19: mechanisms and nutritional management. Nutr Res Rev. 2021;34(2):209-21.
Korakas E, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020;319(1):105-9.
Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract. 2020;14(4):295-300.
Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020;95(7):1445-53.
Huang Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020; 113:1-13.
Ho JSY, Fernando DI, Chan MY, Sia CH. Obesity in COVID-19: A Systematic Review and Meta-analysis. Ann Acad Med Singap. 2020 ;49(12):996-1008.
Leeuw AJM, Luttikhuis MAMO, Wellen AC, Müller C, Calkhoven CF. Obesity and its impact on COVID-19. J Mol Med (Berl). 2021;99(7):899-915.
Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond). 2020;20(4):899-915.
Ritter A, Kreis NN, Louwen F, Yuan J. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics. Int J Mol Sci. 2020;21(16):1-28.
Demeulemeester F, Punder K, Heijningen MV, Doesburg FV. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells. 2021;10(4):1-19.
Yang Jun, et al. Obesity aggravates COVID-19: An updated systematic review and meta-analysis. J Med Virol. 2021;93(5):2662-74.
Yang J, Ma Z, Lei Y. A meta-analysis of the association between obesity and COVID-19. Epidemiol Infect. 2020; 149:1-14.
Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021;35(3):1-15.
Földi M, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020;21(10):1-9.
Popkin BM, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):1–17.
